About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: September 17, 2014
    A substantial body of evidence shows that broad improvements to end-of-life care are within reach. In Dying in America, a consensus report from the Institute of Medicine (IOM), a committee of experts finds that improving the quality and availability of medical and social services for patients and their families could not only enhance quality of life through the end of life, but may also contribute to a more sustainable care system.
  • Released: September 16, 2014
    An IOM study looked at how health systems improvements can lead to better health, reduce poverty, and make donor investment in health sustainable. The resulting report stresses the importance of the health system in making transformative investments that support health in developing countries, and outlines a broad donor strategy that can make effective use of the United States’ comparative advan¬tage in science and technology to improve health for the world’s most vulnerable people.
  • Released: September 10, 2014
    Health literacy is the degree to which individuals can obtain, process, and understand the basic health information and services they need to make appropriate health decisions. The Institute of Medicine convened the Roundtable on Health Literacy to address issues raised in the report, Health Literacy: A Prescription to End Confusion (IOM, 2004). The roundtable sponsored a workshop in Irvine, CA, on November 21, 2013, that focused on the implications of health literacy for the mission and essential services of public health.
  • Released: September 04, 2014
    The April 10, 2014, workshop, titled The Role and Potential of Communities in Improving Population Health, was designed to facilitate discussion about important ingredients, effective strategies, and other lessons learned in three contexts: youth organizing, community organizing or other types of community participation, and partnerships between community and institutional actors (e.g., universities, public health agencies).
  • Released: September 04, 2014
    The April 10, 2014, workshop, titled The Role and Potential of Communities in Improving Population Health, was designed to facilitate discussion about important ingredients, effective strategies, and other lessons learned in three contexts: youth organizing, community organizing or other types of community participation, and partnerships between community and institutional actors (e.g., universities, public health agencies).
  • Released: September 03, 2014
    The Forum on Microbial Threats hosted a public workshop on September 24 and 25, 2013, to explore the scientific and policy dimensions of the impacts of global environmental change on infectious disease dynamics. Participants examined and discussed the observed and likely influences of environmental factors, acting both individually and synergistically on infectious disease dynamics. A range of approaches to improve global readiness and capacity for surveillance, detection, and response to emerging microbial threats to plant, animal, and human health in the face of ongoing global environmental change was also discussed.
  • Released: July 28, 2014
    The Roundtable on Population Health Improvement held a public workshop on February 6, 2014 to explore the range of resources that might be available to provide a secure funding stream for non-clinical actions to enhance health. The workshop featured a number of presentations and discussions, beginning with an overview of the range of potential resources (for example, financial, human, and community) and followed by an in-depth exploration of several dimensions related to financial resources. This document summarizes the workshop.
  • Released: July 22, 2014
    Clinical use of DNA sequencing relies on identifying linkages between diseases and genetic variants or groups of variants. More than 140,000 germline mutations have been submitted to the Human Gene Mutation Database and almost 12,000 single nucleotide polymorphisms have currently been associated with various diseases, including Alzheimer’s and type 2 diabetes, but the majority of associations have not been rigorously confirmed and may play only a minor role in disease. Because of the lack of evidence available for assessing variants, evaluation bodies have made few recommendations for the use of genetic tests in health care.
  • Released: July 22, 2014
    Clinical use of DNA sequencing relies on identifying linkages between diseases and genetic variants or groups of variants. More than 140,000 germline mutations have been submitted to the Human Gene Mutation Database and almost 12,000 single nucleotide polymorphisms have currently been associated with various diseases, including Alzheimer’s and type 2 diabetes, but the majority of associations have not been rigorously confirmed and may play only a minor role in disease. Because of the lack of evidence available for assessing variants, evaluation bodies have made few recommendations for the use of genetic tests in health care.
  • Released: July 14, 2014
    Recognizing the limitations of most SSA countries to effectively treat MNS disorders, the Forum on Neuroscience and Nervous System Disorders of the Institute of Medicine convened a workshop in Addis Ababa, Ethiopia, in January 2014. The workshop brought together key stakeholders to discuss opportunities for achieving long-term affordable access to medicines for MNS disorders and to consider frameworks and strategies that have been successful in other countries and for different diseases. In particular, the workshop was organized around a series of focused discussions on four challenge areas: insufficient demand, inappropriate selection, ineffective supply chains, and high pricing and poor financing. This document summarizes the workshop.
pillsbank.net

www.rezeptfrei-viagra.com